Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Low Genetic Testing Utilization Among Patients with Breast, Ovarian, Pancreatic, and Prostate Cancers

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Childers CP, Childers KK, Maggard-Gibbons M, Macinko J. National estimates of genetic testing in women with a history of breast or ovarian cancer. J Clin Oncol. 2017;35:3800–6. https://doi.org/10.1200/JCO.

    Article  Google Scholar 

  2. Clark NM, Roberts EA, Fedorenko C, et al. Genetic testing among patients with high-risk breast, ovarian, pancreatic, and prostate cancers. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12755-y.

  3. Culver JO, Freiberg Y, Ricker C, et al. Integration of universal germline genetic testing for all new breast cancer patients. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12595-w.

  4. Bokkers K, Vlaming M, Engelhardt EG, et al. The feasibility of implementing mainstream germline genetic testing in routine cancer care: a systematic review. Cancers. 2022;14:1059. https://doi.org/10.3390/cancers14041059.

    Article  CAS  Google Scholar 

  5. Kukafka R, Pan S, Silverman T, et al. Patient and clinician decision support to increase genetic counseling for hereditary breast and ovarian cancer syndrome in primary care: a cluster randomized clinical trial. JAMA Netw Open. 2022;5:e2222092. https://doi.org/10.1001/jamanetworkopen.2022.22092.

    Article  Google Scholar 

Download references

Acknowledgment

This work was funded by a grant from the Athena Foundation.

Author information

Authors and Affiliations

  1. Department of Surgery, University of Washington, Seattle, WA, USA

    Nina M. Clark MD & Meghan R. Flanagan MD, MPH, FACS

  2. Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA

    Meghan R. Flanagan MD, MPH, FACS

Authors
  1. Nina M. Clark MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meghan R. Flanagan MD, MPH, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Meghan R. Flanagan MD, MPH, FACS.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Clark, N.M., Flanagan, M.R. ASO Author Reflections: Low Genetic Testing Utilization Among Patients with Breast, Ovarian, Pancreatic, and Prostate Cancers. Ann Surg Oncol 30, 1327–1328 (2023). https://doi.org/10.1245/s10434-022-12769-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12769-6

Search

Navigation